Sean Michael Smith

Principal Accounting Officer, Neurogene Inc.

Companies

Neurogene Inc.Chief financial officer Aug 14, 2023 to Aug 14, 2023¹
Neurogene Inc.Principal Accounting Officer Mar 3, 2022 to Feb 3, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Neurogene Inc. NGNE21,637 shares³$516.9K at $23.89Aug 11, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 11, 2023Sold 1,323 shares at $0.62 of Neurogene Inc.³
Aug 10, 2023Exercised options 5,000 shares of Neurogene Inc.³
Feb 2, 2023Sold 3,316 shares at $0.60 of Neurogene Inc.⁴
Feb 1, 2023Exercised options 12,500 shares of Neurogene Inc.⁴
Aug 10, 2022Sold 1,655 shares at $0.99 of Neurogene Inc.⁵
Aug 10, 2022Exercised options 5,000 shares of Neurogene Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNeurogene Inc., Chief financial officer
2
SEC EDGARNeurogene Inc., Principal Accounting Officer
3
SEC EDGARNeurogene Inc. shares after the filing of Aug 11, 2023
4
SEC EDGARForm 4 filed Feb 3, 2023
5
SEC EDGARForm 4 filed Aug 12, 2022